The Role of 2-Oxoglutarate Dependent Dioxygenases in Gliomas and Glioblastomas: A Review of Epigenetic Reprogramming and Hypoxic Response
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of 2-Oxoglutarate Dependent Dioxygenases in Gliomas and Glioblastomas: A Review of Epigenetic Reprogramming and Hypoxic Response
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-25
DOI
10.3389/fonc.2021.619300
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IDH mutation in glioma: molecular mechanisms and potential therapeutic targets
- (2020) Sue Han et al. BRITISH JOURNAL OF CANCER
- The histone demethylase JMJD2A promotes glioma cell growth via targeting Akt-mTOR signaling
- (2020) Min Li et al. Cancer Cell International
- Mechanisms and therapeutic implications of hypermutation in gliomas
- (2020) Mehdi Touat et al. NATURE
- Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
- (2020) Faiqa Mudassar et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clinical implications of hypoxia‑inducible factor‑1α and caveolin‑1 overexpression in isocitrate dehydrogenase‑wild type glioblastoma multiforme
- (2019) Wenli Chen et al. Oncology Letters
- Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels
- (2019) Elizabeth J. Campbell et al. BMC CANCER
- Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer
- (2019) Feng Wang et al. BMC CANCER
- Clinical pharmacokinetics and pharmacodynamics of ivosidenib, an oral, targeted inhibitor of mutant IDH1, in patients with advanced solid tumors
- (2019) Bin Fan et al. INVESTIGATIONAL NEW DRUGS
- Phase I study of a brain penetrant mutant IDH1 inhibitor DS-1001b in patients with recurrent or progressive IDH1 mutant gliomas.
- (2019) Atsushi Natsume et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas
- (2019) An-An Yin et al. Clinical Epigenetics
- Brain iron transport
- (2019) Zhong‐Ming Qian et al. BIOLOGICAL REVIEWS
- Epigenetic downregulation of TET3 reduces genome‐wide 5hmC levels and promotes glioblastoma tumorigenesis
- (2019) Antonella Carella et al. INTERNATIONAL JOURNAL OF CANCER
- Publisher Correction: DNA demethylation is associated with malignant progression of lower-grade gliomas
- (2019) Masashi Nomura et al. Scientific Reports
- First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma
- (2019) Bryan G. Allen et al. CLINICAL CANCER RESEARCH
- Vitamin C in combination with inhibition of mutant IDH1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer cells
- (2019) Christian Gerecke et al. Epigenetics
- Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma
- (2019) Makoto Nakagawa et al. ONCOGENE
- 158P Role of iron metabolism in the immunosuppression mediated by myeloid cells in glioblastoma patients
- (2019) S Magri et al. ANNALS OF ONCOLOGY
- Novel IDH1-Targeted Glioma Therapies
- (2019) Georg Karpel-Massler et al. CNS DRUGS
- Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1
- (2019) Andrew B. Das et al. Blood Cancer Journal
- Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C induces epigenetic changes
- (2019) Linn Gillberg et al. Clinical Epigenetics
- 2-Hydroxyglutarate in Cancer Cells
- (2019) Petr Ježek ANTIOXIDANTS & REDOX SIGNALING
- 5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma
- (2018) Wioletta K. Glowacka et al. ACTA NEUROPATHOLOGICA
- 2-Oxoglutarate-Dependent Oxygenases
- (2018) Md. Saiful Islam et al. Annual Review of Biochemistry
- Iron transport kinetics through blood-brain barrier endothelial cells
- (2018) Aminul Islam Khan et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Advances in Hypoxia-Inducible Factor Biology
- (2018) Hani Choudhry et al. Cell Metabolism
- Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma
- (2018) Agustin F Fernandez et al. HUMAN MOLECULAR GENETICS
- Hepcidin, an emerging and important player in brain iron homeostasis
- (2018) Driton Vela Journal of Translational Medicine
- Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B
- (2018) Mikkel Staberg et al. Molecular Oncology
- WHO 2016 Classification of gliomas
- (2018) P. Wesseling et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Epigenetic dysregulation of TET2 in human glioblastoma
- (2018) María G. García et al. Oncotarget
- A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence
- (2018) Camila Ferreira de Souza et al. Cell Reports
- Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer
- (2018) Ding Peng et al. Clinical Epigenetics
- Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide
- (2018) Alessia Lo Dico et al. Frontiers in Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hypoxia-inducible factor 2α: a novel target in gliomas
- (2018) Jaclyn J Renfrow et al. Future Medicinal Chemistry
- Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1α stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment
- (2018) Jianbo Feng et al. ONCOGENE
- Inherent DNA‐binding specificities of the HIF‐1α and HIF‐2α transcription factors in chromatin
- (2018) James A Smythies et al. EMBO REPORTS
- 18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated with Highly Conformal Radiation Therapy
- (2018) Y. Qian et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- RBTT-03. A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PERIOPERATIVE STUDY OF AG-120 (IVOSIDENIB) AND AG-881 IN PATIENTS WITH RECURRENT, NONENHANCING, IDH1-MUTANT, LOW-GRADE GLIOMA
- (2018) Ingo Mellinghoff et al. NEURO-ONCOLOGY
- The Association Between Ascorbate and the Hypoxia-Inducible Factors in Human Renal Cell Carcinoma Requires a Functional Von Hippel-Lindau Protein
- (2018) Christina Wohlrab et al. Frontiers in Oncology
- Pharmacologic ascorbate induces neuroblastoma cell death by hydrogen peroxide mediated DNA damage and reduction in cancer cell glycolysis
- (2017) Enlong Ma et al. FREE RADICAL BIOLOGY AND MEDICINE
- Na+/H+Exchanger 9 Regulates Iron Mobilization at the Blood-Brain Barrier in Response to Iron Starvation
- (2017) Rami Beydoun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GBM radiosensitizers: dead in the water…or just the beginning?
- (2017) Ranjit S. Bindra et al. JOURNAL OF NEURO-ONCOLOGY
- Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme
- (2017) John L. Gainer et al. JOURNAL OF NEUROSURGERY
- Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia
- (2017) M Mingay et al. LEUKEMIA
- Repression of the expression of TET2 by ZEB1 contributes to invasion and growth in glioma cells
- (2017) Bo Chen et al. Molecular Medicine Reports
- Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence
- (2017) Sevin Turcan et al. NATURE GENETICS
- EXTH-34. COMBINED USE OF THE PAN-IDH MUTANT INHIBITOR AG-881 WITH RADIATION THERAPY SHOWS ADDED BENEFIT IN AN ORTHOTOPIC IDH1 MUTANT GLIOMA MODEL IN VIVO
- (2017) Brandon Nicolay et al. NEURO-ONCOLOGY
- Glioma epigenetics: From subclassification to novel treatment options
- (2017) Olga Gusyatiner et al. SEMINARS IN CANCER BIOLOGY
- Vitamin C induces specific demethylation of H3K9me2 in mouse embryonic stem cells via Kdm3a/b
- (2017) Kevin T. Ebata et al. Epigenetics & Chromatin
- Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma
- (2017) et al. Cancers
- The Role of Hypoxia in Glioblastoma Invasion
- (2017) Ana Monteiro et al. Cells
- Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays
- (2017) Daniel J. Urban et al. Scientific Reports
- High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study
- (2017) Kishore Polireddy et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours
- (2016) Katarzyna Stępień et al. MEDICAL ONCOLOGY
- Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas
- (2016) Cody Weston et al. PLoS One
- Retinol and ascorbate drive erasure of epigenetic memory and enhance reprogramming to naïve pluripotency by complementary mechanisms
- (2016) Timothy Alexander Hore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches
- (2016) Wen-Juan Huang et al. Oncology Letters
- 5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients
- (2016) Kevin C. Johnson et al. Nature Communications
- Metabolism and epigenetics in the nervous system: Creating cellular fitness and resistance to neuronal death in neurological conditions via modulation of oxygen-, iron-, and 2-oxoglutarate-dependent dioxygenases
- (2015) Saravanan S. Karuppagounder et al. BRAIN RESEARCH
- Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
- (2015) David L. Schonberg et al. CANCER CELL
- DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors
- (2015) Tali Mazor et al. CANCER CELL
- The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma
- (2015) Barbara Banelli et al. CELL CYCLE
- Effects of High Doses of Vitamin C on Cancer Patients in Singapore
- (2015) Yuen Chuen Fong Raymond et al. INTEGRATIVE CANCER THERAPIES
- Integrated genomic characterization of IDH1-mutant glioma malignant progression
- (2015) Hanwen Bai et al. NATURE GENETICS
- Iron metabolism: a double-edged sword in the resistance of glioblastoma to therapies
- (2015) Claire Legendre et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Loss of 5-hydroxymethylcytosine and intratumoral heterogeneity as an epigenomic hallmark of glioblastoma
- (2015) Theo F. J. Kraus et al. TUMOR BIOLOGY
- High-Dose Vitamin C Promotes Regression of Multiple Pulmonary Metastases Originating from Hepatocellular Carcinoma
- (2015) Min-Seok Seo et al. YONSEI MEDICAL JOURNAL
- Genetic Characterization of Ten-Eleven-Translocation Methylcytosine Dioxygenase Alterations in Human Glioma
- (2015) Theo F. J. Kraus et al. Journal of Cancer
- Vitamin C in Health and Disease: Its Role in the Metabolism of Cells and Redox State in the Brain
- (2015) Rodrigo Figueroa-Méndez et al. Frontiers in Physiology
- Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
- (2015) Serena Pellegatta et al. Acta Neuropathologica Communications
- Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d-2-Hydroxyglutarate
- (2014) Jing Fan et al. ACS Chemical Biology
- Cell-Type-Specific Jumonji Histone Demethylase Gene Expression in the Healthy Rat CNS: Detection by a Novel Flow Cytometry Method
- (2014) Stephanie M.C. Smith et al. ASN Neuro
- Elimination of Ascorbic Acid After High-Dose Infusion in Prostate Cancer Patients: A Pharmacokinetic Evaluation
- (2014) Torben K. Nielsen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21
- (2014) Bin Dai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulation of the 2-oxoglutarate-dependent dioxygenases and implications for cancer
- (2014) Margreet C.M. Vissers et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Iron transport across the blood–brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy
- (2014) Ryan C. McCarthy et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Radiosensitisation by pharmacological ascorbate in glioblastoma multiforme cells, human glial cells, and HUVECs depends on their antioxidant and DNA repair capabilities and is not cancer specific
- (2014) M. Leticia Castro et al. FREE RADICAL BIOLOGY AND MEDICINE
- Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response
- (2014) Caroline Kuiper et al. FREE RADICAL BIOLOGY AND MEDICINE
- The role of iron in brain ageing and neurodegenerative disorders
- (2014) Roberta J Ward et al. LANCET NEUROLOGY
- HIF-1-Dependent Induction of Jumonji Domain-Containing Protein (JMJD) 3 under Hypoxic Conditions
- (2014) Ho-Youl Lee et al. MOLECULES AND CELLS
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- Hypoxia-inducible factor–1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma
- (2014) Matthew Womeldorff et al. Neurosurgical Focus
- Glial Cell Ceruloplasmin and Hepcidin Differentially Regulate Iron Efflux from Brain Microvascular Endothelial Cells
- (2014) Ryan C. McCarthy et al. PLoS One
- The Role of Factor Inhibiting HIF (FIH-1) in Inhibiting HIF-1 Transcriptional Activity in Glioblastoma Multiforme
- (2014) Enfeng Wang et al. PLoS One
- High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
- (2014) Y. Ma et al. Science Translational Medicine
- The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study
- (2014) Sydney M. Evans et al. Translational Oncology
- The roles of Jumonji-type oxygenases in human disease
- (2014) Catrine Johansson et al. Epigenomics
- Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo−/−mice
- (2014) Elizabeth J. Campbell et al. Cancer Medicine
- Labile iron in cells and body fluids: physiology, pathology, and pharmacology
- (2014) Zvi Ioav Cabantchik Frontiers in Pharmacology
- Structure and function of dioxygenases in histone demethylation and DNA/RNA demethylation
- (2014) Cheng Dong et al. IUCrJ
- Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model
- (2014) Carole Grasso et al. Frontiers in Oncology
- Increased Tumor Ascorbate is Associated with Extended Disease-Free Survival and Decreased Hypoxia-Inducible Factor-1 Activation in Human Colorectal Cancer
- (2014) Caroline Kuiper et al. Frontiers in Oncology
- Ascorbate as a Co-Factor for Fe- and 2-Oxoglutarate Dependent Dioxygenases: Physiological Activity in Tumor Growth and Progression
- (2014) Caroline Kuiper et al. Frontiers in Oncology
- Ascorbate-induced generation of 5-hydroxymethylcytosine is unaffected by varying levels of iron and 2-oxoglutarate
- (2013) Kevin M. Dickson et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted?
- (2013) T C Hirst et al. BRITISH JOURNAL OF CANCER
- Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
- (2013) J. L. Welsh et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
- (2013) Christopher M. Stephenson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Dynamic Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized Derivatives
- (2013) Cornelia G. Spruijt et al. CELL
- IDH1 and IDH2 Mutations in Gliomas
- (2013) Adam L. Cohen et al. Current Neurology and Neuroscience Reports
- Effects of Vitamin C on health: a review of evidence
- (2013) Roberto Bei Frontiers in Bioscience-Landmark
- Ferroportin and Exocytoplasmic Ferroxidase Activity Are Required for Brain Microvascular Endothelial Cell Iron Efflux
- (2013) Ryan C. McCarthy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ascorbate Induces Ten-Eleven Translocation (Tet) Methylcytosine Dioxygenase-mediated Generation of 5-Hydroxymethylcytosine
- (2013) Emily A. Minor et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
- (2013) Atsushi Terunuma et al. JOURNAL OF CLINICAL INVESTIGATION
- TET enzymes, TDG and the dynamics of DNA demethylation
- (2013) Rahul M. Kohli et al. NATURE
- Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells
- (2013) Kathryn Blaschke et al. NATURE
- Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine
- (2013) Michael J Booth et al. Nature Protocols
- Cell Cycle-Dependent Turnover of 5-Hydroxymethyl Cytosine in Mouse Embryonic Stem Cells
- (2013) Junji Otani et al. PLoS One
- A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation
- (2013) Mario Iurlaro et al. GENOME BIOLOGY
- Nuclear Exclusion of TET1 Is Associated with Loss of 5-Hydroxymethylcytosine in IDH1 Wild-Type Gliomas
- (2012) Tim Müller et al. AMERICAN JOURNAL OF PATHOLOGY
- Nucleic acid modifications with epigenetic significance
- (2012) Ye Fu et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Pharmacological concentrations of ascorbate radiosensitize glioblastoma multiforme primary cells by increasing oxidative DNA damage and inhibiting G2/M arrest
- (2012) Patries M. Herst et al. FREE RADICAL BIOLOGY AND MEDICINE
- Low values of 5-hydroxymethylcytosine (5hmC), the “sixth base,” are associated with anaplasia in human brain tumors
- (2012) Theo F.J. Kraus et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of high-dose intravenous vitamin C on inflammation in cancer patients
- (2012) Nina Mikirova et al. Journal of Translational Medicine
- IDH mutation impairs histone demethylation and results in a block to cell differentiation
- (2012) Chao Lu et al. NATURE
- Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
- (2012) Peppi Koivunen et al. NATURE
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
- (2012) Sevin Turcan et al. NATURE
- Decreased 5-Hydroxymethylcytosine Is Associated with Neural Progenitor Phenotype in Normal Brain and Shorter Survival in Malignant Glioma
- (2012) Brent A. Orr et al. PLoS One
- Histone Demethylase Jumonji D3 (JMJD3) as a Tumor Suppressor by Regulating p53 Protein Nuclear Stabilization
- (2012) Chibawanye I. Ene et al. PLoS One
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- DNA demethylation by TDG
- (2012) Shannon R Dalton et al. Epigenomics
- High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
- (2011) J. Schodel et al. BLOOD
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- 5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 Mutations
- (2011) S.-G. Jin et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The Histone Demethylases Jhdm1a/1b Enhance Somatic Cell Reprogramming in a Vitamin-C-Dependent Manner
- (2011) Tao Wang et al. Cell Stem Cell
- The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
- (2011) Rasheduzzaman Chowdhury et al. EMBO REPORTS
- Hepcidin directly inhibits transferrin receptor 1 expression in astrocytes via a cyclic AMP-protein kinase a pathway
- (2011) Fang Du et al. GLIA
- TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations
- (2011) Y.-H. Kim et al. JOURNAL OF CLINICAL PATHOLOGY
- R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma
- (2010) Susan C. Williams et al. ACTA NEUROPATHOLOGICA
- Reversal of Histone Methylation: Biochemical and Molecular Mechanisms of Histone Demethylases
- (2010) Nima Mosammaparast et al. Annual Review of Biochemistry
- Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents
- (2010) Emily Flashman et al. BIOCHEMICAL JOURNAL
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- Global Histone Modification Patterns as Prognostic Markers to Classify Glioma Patients
- (2010) B.-l. Liu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Low Ascorbate Levels Are Associated with Increased Hypoxia-Inducible Factor-1 Activity and an Aggressive Tumor Phenotype in Endometrial Cancer
- (2010) C. Kuiper et al. CANCER RESEARCH
- Structural studies on human 2-oxoglutarate dependent oxygenases
- (2010) Michael A McDonough et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry
- (2010) María Berdasco et al. DEVELOPMENTAL CELL
- Hypoxia-Inducible Factors and the Response to Hypoxic Stress
- (2010) Amar J. Majmundar et al. MOLECULAR CELL
- Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis
- (2010) J. Laffaire et al. NEURO-ONCOLOGY
- Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects
- (2010) Sebastian J. Padayatty et al. PLoS One
- Vitamin C Promotes Widespread Yet Specific DNA Demethylation of the Epigenome in Human Embryonic Stem Cells
- (2010) Tung-Liang Chung et al. STEM CELLS
- Vitamin C: update on physiology and pharmacology
- (2009) J Mandl et al. BRITISH JOURNAL OF PHARMACOLOGY
- Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2
- (2009) Fiona E. Harrison et al. FREE RADICAL BIOLOGY AND MEDICINE
- IDH1mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumors
- (2009) Fonnet E. Bleeker et al. HUMAN MUTATION
- Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
- (2009) David R. Mole et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target
- (2009) Randy L. Jensen JOURNAL OF NEURO-ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
- (2009) G L Semenza ONCOGENE
- The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain
- (2009) S. Kriaucionis et al. SCIENCE
- Analysis of the IDH1 codon 132 mutation in brain tumors
- (2008) Jörg Balss et al. ACTA NEUROPATHOLOGICA
- Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
- (2008) L. J. Hoffer et al. ANNALS OF ONCOLOGY
- The human oxygen sensing machinery and its manipulation
- (2008) Rasheduzzaman Chowdhury et al. CHEMICAL SOCIETY REVIEWS
- Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival
- (2008) A. M. Spence et al. CLINICAL CANCER RESEARCH
- Expression of hypoxia inducible factor-1α in tumors of patients with glioblastoma multiforme and transitional meningioma
- (2008) Mehmet Yasar Kaynar et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
- (2008) William G. Kaelin et al. MOLECULAR CELL
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started